Crispr Therapeutics Ag (CRSP)

08:34 AM

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital - TipRanks

08:34 AM

07:54 AM

Crispr Therapeutics AG: Promising Growth with Casgevy Launch and Innovative Pipeline - TipRanks

07:54 AM

Apr 21, 2025

Jump Financial LLC Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 21, 2025

Apr 21, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Apr 21, 2025

Apr 21, 2025

Capital International Sarl Grows Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 21, 2025

Apr 21, 2025

Capital International Investors Grows Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 21, 2025

Apr 20, 2025

5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years - The Motley Fool

Apr 20, 2025

Apr 20, 2025

Leerink Partnrs Issues Negative Outlook for CRSP Earnings - MarketBeat

Apr 20, 2025

Apr 20, 2025

Wells Fargo & Company MN Buys 17,094 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 20, 2025

Apr 18, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Reynders McVeigh Capital Management LLC - MarketBeat

Apr 18, 2025

Apr 18, 2025

Advisory Services Network LLC Lowers Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 18, 2025

Apr 18, 2025

CRISPR Therapeutics stock pops following disclosure of RFK Jr. investment - MSN

Apr 18, 2025

Apr 18, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 4%Here's What Happened - MarketBeat

Apr 18, 2025

Apr 17, 2025

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Apr 17, 2025

Apr 17, 2025

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Crispr Therapeutics AG (CRSP) Receives a Buy from Bank of America Securities - The Globe and Mail

Apr 17, 2025

Apr 17, 2025

BofA Adjusts Price Target for Crispr Therapeutics (CRSP) to $80 | CRSP Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Vanguard Group Inc. Acquires 10,579 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 17, 2025

Apr 16, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

How To Trade (CRSP) - news.stocktradersdaily.com

Apr 15, 2025

Apr 15, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $73.11 Consensus Target Price from Analysts - MarketBeat

Apr 15, 2025

Apr 14, 2025

Gene Therapy Market Anticipated to Witness 20% CAGR Growth by 2029: Top Key Players like Novartis, Roche, CRISPR Therapeutics - PharmiWeb.com

Apr 14, 2025

Apr 14, 2025

CRISPR Therapeutics' (CRSP) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

Apr 14, 2025

Apr 14, 2025

California Public Employees Retirement System Trims Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 14, 2025

Apr 12, 2025

3 Magnificent Stocks That Could Double or More by 2030 - Yahoo Finance

Apr 12, 2025

Apr 12, 2025

443,536 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Bought by Norges Bank - MarketBeat

Apr 12, 2025

Apr 11, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Sets New 12-Month LowTime to Sell? - MarketBeat

Apr 11, 2025

Apr 11, 2025

LPL Financial LLC Buys 42,232 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 11, 2025

Apr 11, 2025

CRISPR Therapeutics: Is This Biotech Surge Here to Stay? - timothysykes.com

Apr 11, 2025

Apr 11, 2025

First Week of May 30th Options Trading For CRISPR Therapeutics (CRSP) - Nasdaq

Apr 11, 2025

Apr 11, 2025

Goldman Sachs maintains Neutral on CRISPR Therapeutics stock By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

Goldman Sachs maintains Neutral on CRISPR Therapeutics stock - Investing.com

Apr 11, 2025

Apr 11, 2025

47,840 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Bought by ExodusPoint Capital Management LP - MarketBeat

Apr 11, 2025

Apr 11, 2025

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? - AOL.com

Apr 11, 2025

Apr 10, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Given Average Rating of "Hold" by Brokerages - MarketBeat

Apr 10, 2025

Apr 10, 2025

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

Genome Editing Market Growth 2025: Trends, Consumer Demand, - openPR.com

Apr 10, 2025

Apr 09, 2025

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN

Apr 09, 2025

Apr 09, 2025

Crispr Therapeutics AG: Strong Market Position and Financial Stability Justify Buy Rating - TipRanks

Apr 09, 2025

Apr 07, 2025

Layoff Tracker: Spark Lays Off 298 Employees - BioSpace

Apr 07, 2025

Apr 07, 2025

CRSP Stock Touches 52-Week Low at $30.8 Amidst Yearly Decline - Investing.com

Apr 07, 2025

Apr 07, 2025

Genome Engineering Market to Witness Remarkable Growth with - openPR.com

Apr 07, 2025